loading
전일 마감가:
$38.71
열려 있는:
$39.09
하루 거래량:
1.57M
Relative Volume:
0.67
시가총액:
$4.78B
수익:
-
순이익/손실:
$-472.34M
주가수익비율:
-9.9327
EPS:
-4.1459
순현금흐름:
$-340.33M
1주 성능:
+5.26%
1개월 성능:
+44.32%
6개월 성능:
+26.81%
1년 성능:
+49.25%
1일 변동 폭
Value
$38.68
$41.66
1주일 범위
Value
$36.69
$41.66
52주 변동 폭
Value
$22.96
$43.15

Viking Therapeutics Inc Stock (VKTX) Company Profile

Name
명칭
Viking Therapeutics Inc
Name
전화
858-704-4660
Name
주소
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Name
직원
59
Name
트위터
@viking_vktx
Name
다음 수익 날짜
2026-07-22
Name
최신 SEC 제출 서류
Name
VKTX's Discussions on Twitter

Compare VKTX vs VRTX, REGN, ARGX, ALNY, RVMD

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
VKTX icon
VKTX
Viking Therapeutics Inc
41.14 4.35B 0 -472.34M -340.33M -4.1459
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
520.05 134.02B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
669.42 68.59B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
925.67 58.44B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
320.09 41.76B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
188.95 40.23B 742.00K -1.37B -1.07B -7.0731

Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2026-03-26 개시 Wolfe Research Peer Perform
2025-10-29 개시 Canaccord Genuity Buy
2025-04-29 개시 Cantor Fitzgerald Overweight
2025-04-08 개시 Goldman Neutral
2025-02-13 개시 Scotiabank Sector Outperform
2025-02-07 개시 Citigroup Neutral
2024-12-02 개시 Piper Sandler Overweight
2024-11-22 개시 B. Riley Securities Buy
2024-11-04 재확인 H.C. Wainwright Buy
2024-09-11 개시 JP Morgan Overweight
2024-06-27 개시 Morgan Stanley Overweight
2024-05-16 업그레이드 Raymond James Outperform → Strong Buy
2024-03-26 재확인 Oppenheimer Outperform
2024-03-07 개시 Jefferies Buy
2024-02-28 재확인 Oppenheimer Outperform
2023-05-31 재개 ROTH MKM Buy
2023-03-28 재확인 Maxim Group Buy
2023-03-17 개시 Stifel Buy
2021-07-29 재개 BTIG Research Buy
2021-05-25 다운그레이드 Raymond James Strong Buy → Outperform
2020-06-05 개시 BMO Capital Markets Outperform
2020-05-05 개시 Chardan Capital Markets Buy
2020-05-01 개시 BTIG Research Buy
2019-07-16 개시 Oppenheimer Outperform
2019-06-25 개시 Stifel Buy
2019-03-29 업그레이드 SVB Leerink Mkt Perform → Outperform
2019-03-14 재확인 Maxim Group Buy
2019-02-22 개시 SVB Leerink Mkt Perform
2018-12-12 개시 B. Riley FBR Buy
2018-11-19 업그레이드 Raymond James Outperform → Strong Buy
2018-09-18 재확인 H.C. Wainwright Buy
2018-09-18 재확인 Maxim Group Buy
2018-09-18 재확인 Raymond James Outperform
2018-07-20 개시 SunTrust Buy
2018-06-28 개시 Raymond James Outperform
2018-06-01 재확인 Laidlaw Buy
2018-05-31 재확인 Maxim Group Buy
2018-03-26 재개 H.C. Wainwright Buy
2017-11-28 재확인 Maxim Group Buy
2017-11-21 개시 ROTH Capital Buy
모두보기

Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스

pulisher
10:52 AM

CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026? - The Motley Fool

10:52 AM
pulisher
09:24 AM

Piper Sandler reiterates Overweight on Viking Therapeutic stock - Investing.com

09:24 AM
pulisher
07:16 AM

How Much Could $1,000 Invested in Viking Therapeutics Be Worth by 2030? - AOL.com

07:16 AM
pulisher
03:52 AM

Viking Therapeutics (VKTX) Starts VK3019 Trial As Obesity Pipeline Narrative Meets Valuation - simplywall.st

03:52 AM
pulisher
Jul 06, 2026

Viking Therapeutics (NASDAQ: VKTX) Faces Uphill Battle In $150 Billion GLP-1 Race Toward 2030 - foreignpolicyjournal.com

Jul 06, 2026
pulisher
Jul 06, 2026

OABI,VKTX Revenue Breakdown - Finviz

Jul 06, 2026
pulisher
Jul 06, 2026

CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Jul 06, 2026
pulisher
Jul 06, 2026

CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Jul 06, 2026
pulisher
Jul 06, 2026

Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years? - Yahoo Finance

Jul 06, 2026
pulisher
Jul 05, 2026

VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline - Stocktwits

Jul 05, 2026
pulisher
Jul 05, 2026

VKTX Stock Has Nearly 300% Wall Street Upside — Is Viking’s Oral Obesity Pill The Next Novo Nordisk-Style Breakout? - Stocktwits

Jul 05, 2026
pulisher
Jul 04, 2026

VKTX Stock Outpaces LLY, ALT Ahead Of Earnings – Retail Eyes Breakout Ahead - Stocktwits

Jul 04, 2026
pulisher
Jul 04, 2026

Quick ratio of Viking Therapeutics, Inc. – XETR:1VT - TradingView

Jul 04, 2026
pulisher
Jul 04, 2026

Is Viking Therapeutics Stock Going to $50? Here's What the Bulls and Bears Are Saying - The Motley Fool

Jul 04, 2026
pulisher
Jul 03, 2026

VKTXViking Therapeutics Inc Options - Finviz

Jul 03, 2026
pulisher
Jul 03, 2026

VKTX Stock Extends Red-Hot Streak: Insider Scoops Up Shares As Multiple Phase 3 Trials Loom This Year In Obesity Race - Stocktwits

Jul 03, 2026
pulisher
Jul 03, 2026

Viking Therapeutics Moves Closer To Challenging Ozempic With Phase 3 Trial Progress - Stocktwits

Jul 03, 2026
pulisher
Jul 03, 2026

Here's Why Viking Therapeutics Stock Surged Higher in June - The Motley Fool

Jul 03, 2026
pulisher
Jul 01, 2026

Viking Therapeutics, Inc. (VKTX) sees a more significant dip than broader market: Some facts to know - MSN

Jul 01, 2026
pulisher
Jul 01, 2026

Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance

Jul 01, 2026
pulisher
Jul 01, 2026

Is Viking Therapeutics Stock Going to $100? - The Motley Fool

Jul 01, 2026
pulisher
Jul 01, 2026

Viking Therapeutics, Inc. (VKTX) Latest Stock News & Headlines - Yahoo Finance

Jul 01, 2026
pulisher
Jul 01, 2026

Why Viking Therapeutics (VKTX) Is Up 22.2% After Advancing VK3019 Into First-in-Human Obesity Trial - Sahm

Jul 01, 2026
pulisher
Jul 01, 2026

Cantor Fitzgerald reiterates Viking Therapeutic stock rating at Overweight - Investing.com

Jul 01, 2026
pulisher
Jul 01, 2026

Cantor Fitzgerald reiterates Viking Therapeutic stock rating at Overweight By Investing.com - Investing.com Canada

Jul 01, 2026
pulisher
Jun 30, 2026

Viking Therapeutics holds at $5B valuation amid GLP-1 drug competition and awaits oral study results. - Pluang

Jun 30, 2026
pulisher
Jun 30, 2026

VKTX Stock Clocks Best Day In Nearly 3 Months On Obesity Pipeline Optimism, Buyout Speculation - Stocktwits

Jun 30, 2026
pulisher
Jun 30, 2026

Viking Therapeutics: Updating Pipeline Potential As Oral GLP‑1s Accelerate (NASDAQ:VKTX) - Seeking Alpha

Jun 30, 2026
pulisher
Jun 30, 2026

Can Eli Lilly's New Drugs Fuel Growth Beyond Its GLP-1 Blockbusters? - TradingView

Jun 30, 2026
pulisher
Jun 30, 2026

VKTX.O - Reuters

Jun 30, 2026
pulisher
Jun 29, 2026

Is Viking Therapeutics stock a no-brainer buy below $35? - MSN

Jun 29, 2026
pulisher
Jun 29, 2026

Is it worth investing in Viking Therapeutics (VKTX) based on Wall Street's bullish views? - MSN

Jun 29, 2026
pulisher
Jun 29, 2026

(VKTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Jun 29, 2026
pulisher
Jun 29, 2026

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - Yahoo Finance

Jun 29, 2026
pulisher
Jun 29, 2026

Viking Therapeutics (VKTX) Starts A Phase 1 Obesity Trial, Is The Upside Already Priced In? - simplywall.st

Jun 29, 2026
pulisher
Jun 29, 2026

VKTX Stock Draws Fresh Attention Ahead Of Earnings: Wall Street Sees Over 170% Upside As GLP-1 Race Burns Hot - Stocktwits

Jun 29, 2026
pulisher
Jun 29, 2026

VKTX Stock Rises After-Hours: CNBC Flags Viking As Likely Buyout Target This Year As Big Pharma Hunts Next GLP-1 Winner - Stocktwits

Jun 29, 2026
pulisher
Jun 28, 2026

ETFs Investing in Viking Therapeutics, Inc. Stocks - TradingView

Jun 28, 2026
pulisher
Jun 27, 2026

VKTX Stock On Track For Five Consecutive Days Of Gains — Viking Launches Human Trial For Novel Obesity Drug VK3019 - Stocktwits

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to EBITDA forward of Viking Therapeutics, Inc. – NASDAQ:VKTX - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to EBIT forward of Viking Therapeutics, Inc. – NASDAQ:VKTX - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

A New Obesity Drug Just Reached Human Trials. Here's What Comes Next - Streetwise Reports

Jun 27, 2026
pulisher
Jun 27, 2026

Price to earnings forward of Viking Therapeutics, Inc. – NASDAQ:VKTX - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to EBIT forward of Viking Therapeutics, Inc. – FWB:1VT - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to sales forward of Viking Therapeutics, Inc. – NASDAQ:VKTX - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to EBIT forward of Viking Therapeutics, Inc. – LS:A12GD6 - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to revenue forward of Viking Therapeutics, Inc. – NASDAQ:VKTX - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to sales forward of Viking Therapeutics, Inc. – FWB:1VT - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to book forward of Viking Therapeutics, Inc. – NASDAQ:VKTX - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

VKTX Eyes Worst Week Since November As Trial Data Looms — Wall Street Still Sees 200% Upside - Stocktwits

Jun 26, 2026
pulisher
Jun 26, 2026

VKTX Stock Price, Quote & Chart - ChartMill

Jun 26, 2026

Viking Therapeutics Inc (VKTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Viking Therapeutics Inc 주식 (VKTX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
ZANTE GREG
Chief Financial Officer
Jan 05 '26
Sale
32.90
57,661
1,896,969
189,891
Mancini Marianna
Chief Operating Officer
Jan 05 '26
Sale
32.98
57,661
1,901,405
409,190
Lian Brian
President & CEO
Jan 05 '26
Sale
32.96
233,409
7,692,121
2,499,291
FOEHR MATTHEW W
Director
Jan 02 '26
Option Exercise
3.33
16,000
53,280
148,036
FOEHR MATTHEW W
Director
Jan 02 '26
Sale
35.11
16,000
561,694
132,036
$113.49
price up icon 1.16%
$35.27
price up icon 0.23%
$57.95
price up icon 1.95%
ONC ONC
$308.33
price down icon 0.48%
$82.23
price up icon 0.32%
$190.47
price up icon 0.31%
자본화:     |  볼륨(24시간):